Genomic technologies not only help to identify cancers, but also offer opportunities for assessing the potential efficacy of different treatment options. By analyzing the genomic profile of a particular patient, doctors can see which medications might offer the most support, and which could cause more harm. The post Oncologists Turn To Genomics For Improved Answers…
Many of today’s systems weren’t built for speed, supervision, or scale, and they can’t support the level of intelligence or flexibility that modern care delivery demands. The solution isn’t to retreat from APPs. It’s to invest in models that make their work safe, effective, and scalable. The post The Future of Specialty Care: APPs, MDs,…
Economist Vivian Ho has been researching the U.S. health care system for four decades. These days, she’s focused on what she thinks are the biggest burdens on the average American: runaway hospital prices and rising health insurance premiums. She has developed a strategy for addressing high insurance premiums — one that’s based on giving patients…
A large study from Massachusetts has found that babies whose mothers had covid-19 while pregnant were slightly more likely to have a range of neurodevelopmental diagnoses by age 3. Most of these children had speech or motor delays, and the link was strongest in boys and when the mother was infected late in pregnancy. The…
The distress that Will Bynum later recognized as shame settled over him nearly immediately. Bynum, then in his second year of residency training as a family medicine physician, was wrapping up a long shift when he was called into an emergency delivery. To save the baby’s life, he used a vacuum device, which applies suction…
By STEVEN ZECOLA Artificial intelligence (“AI”) has taken root in the field of drug discovery and development and already has shown signs of running past the traditional model of doing research. Congress should take note of these rapid changes and: 1) direct the Department of Health and Human Services (“HHS”) to phase down the government’s…
The billionaire Mark Cuban whose Cost Plus Drugs company has been shaking up the world of prescription drug coverage minces no words when it comes to the role of employers in bringing down healthcare costs. But some employers believe he is wrong. The post Is Mark Cuban Wrong About Employers, PBMs and Drug Prices? appeared…
Nearly 40,000 people have signed a petition from the Alliance for Women’s Health and Prevention’s EveryBODY Covered Campaign urging employers to recognize obesity as a chronic condition and expand comprehensive coverage. The post Nearly 40,000 People Urge Employers to Cover Comprehensive Obesity Care appeared first on MedCity News.
Sarepta Therapeutics attributed the Phase 3 failure to the Covid-19 pandemic, during which many patients missed multiple doses of its Duchenne muscular dystrophy therapies. The company plans to discuss with the FDA traditional regulatory approvals based on the totality of data that includes real world evidence from the years these drugs have been commercially available…
Jennifer Thompson, Medtronic’s vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters’ MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks. The post Medtronic Exec: AI Is Improving Device Launches & Patient Outcomes appeared first on…